Tianjin Cancer Hospital Airport Hospital — Tianjin

Public research footprint of Tianjin Cancer Hospital Airport Hospital, compiled from the ClinicalTrials.gov public registry.

Registered studies

Active

Recruiting now

Stopped or withdrawn

Most-studied conditions

HER2-positive Breast Cancer · NSCLC (Advanced Non-small Cell Lung Cancer) · Hepatocellular Carcinoma · Solid Tumors

Recently updated registry entries

NCT06790693 — A Study Evaluating the Efficacy and Safety of Inavolisib Plus CDK4/6 Inhibitor and… (Recruiting)
NCT07479485 — MRG006A Combination Therapy for Advanced Hepatocellular Carcinoma (Phase I/II) (Recruiting)
NCT07729033 — A Phase II Exploratory Study of Sacituzumab Tirumotecan Combined With Envafolimab for… (Not Yet Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Tianjin Cancer Hospital Airport Hospital?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 05, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.